AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 62 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $17,739,000 | +30.0% | 1,703,987 | +13.1% | 0.00% | 0.0% |
| Q3 2016 | $13,641,000 | +29.5% | 1,507,238 | +7.0% | 0.00% | +50.0% |
| Q2 2016 | $10,536,000 | -10.1% | 1,408,498 | +8.2% | 0.00% | -33.3% |
| Q1 2016 | $11,726,000 | -11.5% | 1,301,449 | +26.9% | 0.00% | 0.0% |
| Q4 2015 | $13,250,000 | +34.3% | 1,025,535 | +0.4% | 0.00% | 0.0% |
| Q3 2015 | $9,864,000 | -3.1% | 1,021,144 | +3.2% | 0.00% | +50.0% |
| Q2 2015 | $10,182,000 | +93.4% | 989,523 | +108.7% | 0.00% | +100.0% |
| Q1 2015 | $5,266,000 | -1.1% | 474,023 | +3.7% | 0.00% | 0.0% |
| Q4 2014 | $5,323,000 | +27.7% | 457,284 | +142.8% | 0.00% | 0.0% |
| Q3 2014 | $4,169,000 | -22.2% | 188,375 | -2.3% | 0.00% | -50.0% |
| Q2 2014 | $5,358,000 | – | 192,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
| Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
| Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
| Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
| Ergoteles LLC | 849,000 | $300,000 | 0.01% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
| Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |